2m 2m 2m 2m 2m 2m 2m
BRIDGEBIO PHARMA (BBIO)
NASDAQ
$81.50$0.00 (0.00%)
Price as of Aug 21, 2026 7:30 PM EDT- $15.9BMarket Cap
- 66.06%1-Year Change
- BiotechnologyIndustry
BRIDGEBIO PHARMA (BBIO)
$81.50$0.00 (0.00%)
BBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $81.50 | ||
Change | -$1.44 (-1.74%) | ||
Open | $82.89 | ||
High | $83.37 | ||
Low | $81.36 | ||
Previous Close | $82.94 | ||
Volume | 1,819,209 | ||
30-Day Average Volume | 2,237,634 | ||
1-Week Change | 2.05% | ||
1-Month Change | -1.15% | ||
1-Year Change | 66.06% | ||
3-Year Change | 184.97% | ||
5-Year Change | 66.22% | ||
Fundamentals | |||
Shares Outstanding | 195.5M | ||
Total Assets | $1.2B | ||
Market Cap | $15.9B | ||
Enterprise Value | $15.8B | ||
Period: QTR TTM FY | |||
Revenue | $222.4M | ||
Net Income | -$155.9M | ||
Free Cash Flow | -$71.5M | ||
EBIT | -$152.0M | ||
EBITDA | -$150.9M | ||
Net Working Capital | $202.5M | ||
EPS | -$0.78 | ||
Enterprise Value/EBITDA | -105 | ||
Enterprise Value/Revenue | 71 | ||
P/B | -6 | ||
P/E | -104 | ||
PEG | -15 | ||
Price/Free Cash Flow | -223 | ||
Price/Operating Cash Flow | -224 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue